ProCE Banner Activity

Ключевые исследования ВИЧ, повлиявшие на мою работу, по итогам IDWeek и HIV Glasgow 2022*

Slideset Download
Conference Coverage

Ознакомьтесь с обзорами ключевых исследований ВИЧ по итогам IDWeek и HIV Glasgow 2022, составленными экспертным профессорским составом, включая результаты исследований стратегий профилактики, длительного лечения, ежедневного перорального лечения, экспериментальных препаратов и взаимодействия ВИЧ и COVID-19.

Released: December 16, 2022

Share

Faculty

Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Karine Lacombe

Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Babafemi Taiwo

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Cheif
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Joseph J. Eron Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Джозеф Дж. Эрон-младший, доктор медицины (MD): консультант/эксперт/лектор: Gilead Sciences, GlaxoSmithKline, Janssen, Merck, ViiV Healthcare; исследователь: Gilead Sciences, ViiV Healthcare.

Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Карин Лакомб, доктор медицины (MD), PhD: консультант/эксперт/лектор: Gilead Sciences, GlaxoSmithKline, Janssen, MSD.

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Queen Mary University of London
The Royal London Hospital
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead, GSK, MSD, ViiV; researcher: AstraZeneca, Gilead, GSK, MSD, ViiV.

Babafemi Taiwo, MBBS

Gene Stollerman Professor of Medicine
Cheif
Division of Infectious Diseases
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Бабафеми Тайво, бакалавр медицины и бакалавр хирургии (MBBS): консультант/эксперт/лектор: Gilead Sciences, Johnson & Johnson, ViiV Healthcare.